Sign in

CIK 0001390478

  • Non-accelerated filer
  • Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-200-5278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$716,682
in 3 filings

Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2009-01-15 Pavco Pamela VP of Pharmaceutical Devlpmt. Grant or award · Stock Option +47,000 234,137
2009-01-15 GALLIKER STEPHEN S Director Grant or award · Stock Option +50,000 150,000
2009-01-15 KRIEGSMAN STEVEN A Director Grant or award · Stock Option +50,000 150,000
2009-01-15 Hillsberg Sanford Director Grant or award · Stock Option +50,000 150,000
2009-01-15 Ahn Mark J Director Grant or award · Stock Option +50,000 150,000
2009-01-15 Nisi Rudolph Director Grant or award · Stock Option +35,500 50,000
2008-10-17 Khvorova Anastasia Chief Scientific Officer Grant or award · Employee Stock Option +151,652 190,000
2008-10-17 Khvorova Anastasia Chief Scientific Officer Grant or award · Employee Stock Option +38,348 190,000
2008-04-18 Woolf Tod President and CEO Grant or award · Incentive Stock Option +55,106 55,106
2008-04-18 Samarsky Dmitry VP, Technology Development Grant or award · Incentive Stock Option +22,699 22,699
2008-04-18 Pavco Pamela VP of Pharmaceutical Devlpmt. Grant or award · Incentive Stock Option +41,826 41,826
2008-04-18 KRIEGSMAN STEVEN A Director Grant or award · Non-Qualified Stock Option +25,000 25,000
2008-04-18 DiPalma Stephen J. CFO and Secretary Grant or award · Incentive Stock Option +19,428 19,428
2008-04-18 Hillsberg Sanford Director Grant or award · Non-Qualified Stock Option +25,000 25,000
2008-04-18 GALLIKER STEPHEN S Director Grant or award · Non-Qualified Stock Option +25,000 25,000
2008-04-18 Ahn Mark J Director Grant or award · Non-Qualified Stock Option (right to buy) +25,000 25,000
2008-03-11 KRIEGSMAN STEVEN A Director Other acquisition +8,990 8,990
2008-03-11 KRIEGSMAN STEVEN A Director Other acquisition +200,594 209,584
2008-03-11 CYTRX CORP 10% owner Other disposition −4,526,624 6,296,575
2008-03-11 CYTRX CORP 10% owner Other disposition −27,694 6,268,881

Page 29 of 29 · 580 trades